CDK inhibitor P276-00
Term · Oncology and biomedicine · MLC-T-ONC-012436
A flavone and cyclin dependent kinase (CDK) inhibitor with potential antineoplastic activity. P276-00 selectively binds to and inhibits Cdk4/cyclin D1, Cdk1/cyclin B and Cdk9/cyclin T1, serine/threonine kinases that play key roles in the regulation of the cell cycle and cellular proliferation. Inhibition of these kinases leads to cell cycle arrest during the G1/S transition, thereby leading to an induction of apoptosis, and inhibition of tumor cell proliferation.
| Identifier | MLC-T-ONC-012436 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | cyclin-dependent kinase inhibitor P276 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-012436",
"term": "CDK inhibitor P276-00",
"field": "Oncology and biomedicine",
"definition": "A flavone and cyclin dependent kinase (CDK) inhibitor with potential antineoplastic activity. P276-00 selectively binds to and inhibits Cdk4/cyclin D1, Cdk1/cyclin B and Cdk9/cyclin T1, serine/threonine kinases that play key roles in the regulation of the cell cycle and cellular proliferation. Inhibition of these kinases leads to cell cycle arrest during the G1/S transition, thereby leading to an induction of apoptosis, and inhibition of tumor cell proliferation.",
"synonyms": [
"cyclin-dependent kinase inhibitor P276"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/cdk-inhibitor-p276-00/"
}
Record 4,462 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.